article thumbnail

10 of our most read articles in 2023

PharmaVoice

A presidential candidate, a changing biotech market and an enduring murder mystery — here are PharmaVoice’s most-read articles this year.

130
130
article thumbnail

ARCH Venture Partners rises to the top of STAT’s 2023 biotech VC rankings

STAT

This article is adapted from the 2023 edition of STAT’s annual report, “Ranking biotech’s top venture capital firms.”   Read the rest…

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ALiEM AIR Series | Trauma 2023 Module

ALiEM - Pharm Pearls

2023.02.011 , PMID 36967275 Author information Chris Belcher, MD Editor, ALiEM AIR Series Assistant Professor and Assistant Program Director Department of Emergency Medicine University of Kentucky College of Medicine | Twitter | The post ALiEM AIR Series | Trauma 2023 Module appeared first on ALiEM. Ann Emerg Med. 2023;82(1):55-65.

Labelling 211
article thumbnail

Top 5 Pharmacy Times Specialty Pharmacy Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read specialty pharmacy-related articles on Pharmacy Times in 2023.

article thumbnail

Top 5 Pharmacy Times Pediatrics Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read pediatrics-related articles on Pharmacy Times in 2023.

49
article thumbnail

Top 5 Pharmacy Times Oncology Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read oncology-related articles on Pharmacy Times in 2023.

49
article thumbnail

Opinion: Buprenorphine, autism diagnoses, and long Covid: the most-read First Opinion essays of 2023

STAT

Below, you’ll find our top six most-read articles of the year by page views. And if your holiday plans mean you’re spending some time traveling, be sure to catch up with the “ First Opinion Podcast ,” where I speak with authors of recent First Opinion essays about their articles — and much more.

274
274